Abstract:Importance: Antidepressant responses and the phenotype of treatment-resistant depression (TRD) are believed to have a genetic basis. Genetic susceptibility between the TRD phenotype and other psychiatric disorders has also been established in previous genetic studies, but population-based cohort studies have not yet provided evidence to support these outcomes. Objective: To estimate the TRD susceptibility and the susceptibility between TRD and other psychiatric disorders within families in a nationwide insurance cohort with extremely high coverage and comprehensive health care data. Design, setting, and participants: This cohort study assessed data from the Taiwan national health insurance database across entire population (N = 26 554 001) between January 2003 and December 2017. Data analysis was performed from August 2021 to April 2023. TRD was defined as having experienced at least 3 distinct antidepressant treatments in the current episode, each with adequate dose and duration, based on the prescribing records. Then, we identified the first-degree relatives of individuals with TRD (n = 34 467). A 1:4 comparison group (n = 137 868) of first-degree relatives of individuals without TRD was arranged for the comparison group, matched by birth year, sex, and kinship. Main outcomes and measures: Modified Poisson regression analyses were performed and adjusted relative risks (aRRs) and 95% CIs were calculated for the risk of TRD, the risk of other major psychiatric disorders, and different causes of mortality. Results: This study included 172 335 participants (88 330 male and 84 005 female; mean [SD] age at beginning of follow-up, 22.9 [18.1] years). First-degree relatives of individuals with TRD had lower incomes, more physical comorbidities, higher suicide mortality, and increased risk of developing TRD (aRR, 9.16; 95% CI, 7.21-11.63) and higher risk of other psychiatric disorders than matched control individuals, including schizophrenia (aRR, 2.36; 95% CI, 2.10-2.65), bipolar disorder (aRR, 3.74; 95% CI, 3.39-4.13), major depressive disorder (aRR, 3.65; 95% CI, 3.44-3.87), attention-deficit/hyperactivity disorders (aRR, 2.38; 95% CI, 2.20-2.58), autism spectrum disorder (aRR, 2.26; 95% CI, 1.86-2.74), anxiety disorder (aRR, 2.71; 95% CI, 2.59-2.84), and obsessive-compulsive disorder (aRR, 3.14; 95% CI, 2.70-3.66). Sensitivity and subgroup analyses validated the robustness of the findings. Conclusions and relevance: To our knowledge, this study is the largest and perhaps first nationwide cohort study to demonstrate TRD phenotype transmission across families and coaggregation with other major psychiatric disorders. Patients with a family history of TRD had an increased risk of suicide mortality and tendency toward antidepressant resistance; therefore, more intensive treatments for depressive symptoms might be considered earlier, rather than antidepressant monotherapy.

Clinical Characteristics of Treatment-Resistant Depression with and Without Anxious Features

Risk Factors for Anxiety in Major Depressive Disorder Patients

Risk factors of suicidal attempt in major depressive disorder patients with anxious characteristics

Risk factors of anxious symptoms in patients with bipolar disorder

Risk factors of suicidality in major depressive disorder patients with and without anxious characteristics

Prevalence and Clinical Features of Atypical Depression among Patients with Major Depressive Disorder in China.

Multi-center study of the clinical features in depression comorbidity with anxiety disorders

Comparison on the clinical features in patients with or without treatment-resistant depression: A National Survey on Symptomatology of Depression report

The Prevalence and Clinical Correlates of Anxiety in Chinese Patients with First-Episode and Drug-Naïve Major Depressive Disorder at Different Ages of Onset

Investigation of early and lifetime clinical features and comorbidities for the risk of developing treatment-resistant depression in a 13-year nationwide cohort study

A comparison of clinical characteristics between treatment-resistant depressed patients with and without current suicidal ideation

The Relevant Research of Thyroid Hormones and Clinical Features in Treatment-Resistant Depression

Clinical and Biological Factors Are Associated with Treatment-Resistant Depression

The characteristics of sympathetic skin response in patients with depression

Susceptibility to Treatment-Resistant Depression Within Families

Prevalence and clinical profile of comorbid anxiety in young adult patients with first-episode and drug-naive major depressive disorder

Characterising anxiety in major depressive disorder and its use in predicting antidepressant treatment outcome: An iSPOT-D report

Anxious-depressive attack and rejection sensitivity-Toward a new approach to treatment-resistant depression

The complexity of treatment-resistant depression: A data-driven approach

Different characteristics of striatal resting-state functional conectivity in treatment-resistant and non-treatment-resistant depression

Characteristics and symptomatology of major depressive disorder with atypical features from symptom to syndromal level